Neurobiology of chronic mild stress: Parallels to major depression

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 9, 2012, Pages 2085-2117

  Hill, Matthew N ^a   Hellemans, Kim G C ^b   Verma, Pamela ^c   Gorzalka, Boris B ^c   Weinberg, Joanne ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b CARLETON UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal model; Depression; HPA axis; Neurobiology; Stress

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ANTIDEPRESSANT AGENT; ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; ENDOCANNABINOID; GLUCOCORTICOID RECEPTOR; GLUTAMIC ACID; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; MONOAMINE; NEUROPEPTIDE; NEUROTROPHIN; NORADRENALIN; OPIATE; SEROTONIN;

ANHEDONIA; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MILD STRESS; CLINICAL RESEARCH; DEPRESSION; DISEASE MODEL; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; HUMAN; LONG TERM EXPOSURE; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; REWARD; SIGNAL TRANSDUCTION; STRESS; SYSTEMATIC REVIEW;

ANIMALS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 84865594989     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.07.001     Document Type: Review

References (260)

1. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
2. Allaman I., Papp M., Kraftsik R., Fiumelli H., Magistretti P.J., Martin J.L. Expression of brain-derived neurotrophic factor is not modulated by chronic mild stress in the rat hippocampus and amygdala. Pharmacological Reports 2008, 60:1001-1007.
3. Allard P., Norlen M. Caudate nucleus dopamine D(2) receptors in depressed suicide victims. Neuropsychobiology 2001, 44:70-73.
4. Alonso R., Griebel G., Pavone G., Stemmelin J., Fur G.L., Soubrie P. Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Molecular Psychiatry 2004, 9:278-286. p. 224.
5. American Psychiatric Association Task Force on DSM-IV, 2000. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th, text revision ed.
6. Anisman H., Prakash P., Merali Z., Poulter M.O. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behavioural Brain Research 2007, 181:180-190.
7. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research 1995, 688:121-133.
8. Arango V., Underwood M.D., Mann J.J. Alterations in monoamine receptors in the brain of suicide victims. Journal of Clinical Psychopharmacology 1992, 12:8S-12S.
9. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., Reis D.J., Mann J.J. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Archives of General Psychiatry 1990, 47:1038-1047.
10. Araujo A.P., DeLucia R., Scavone C., Planeta C.S. Repeated predictable or unpredictable stress: effects on cocaine-induced locomotion and cyclic AMP-dependent protein kinase activity. Behavioural Brain Research 2003, 139:75-81.
11. Bambico F.R., Nguyen N.T., Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. European Neuropsychopharmacology 2009, 19:215-228.
12. Banasr M., Chowdhury G.M., Terwilliger R., Newton S.S., Duman R.S., Behar K.L., Sanacora G. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Molecular Psychiatry 2010, 15:501-511.
13. Banasr M., Duman R.S. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biological Psychiatry 2008, 64:863-870.
14. Banasr M., Valentine G.W., Li X.Y., Gourley S.L., Taylor J.R., Duman R.S. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biological Psychiatry 2007, 62:496-504.
15. Banki C.M., Bissette G., Arato M., O'Connor L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. The American Journal of Psychiatry 1987, 144:873-877.
16. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005, 128:1301-1313.
17. Barr A.M., Kinney J.W., Hill M.N., Lu X., Biros S., Rebek J., Bartfai T. A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neuroscience Letters 2006, 405:111-115.
18. Basso A.M., Depiante-Depaoli M., Cancela L., Molina V. Seven-day variable-stress regime alters cortical beta-adrenoceptor binding and immunologic responses: reversal by imipramine. Pharmacology, Biochemistry, and Behavior 1993, 45:665-672.
19. Bekris S., Antoniou K., Daskas S., Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behavioural Brain Research 2005, 161:45-59.
20. Bergstrom A., Jayatissa M.N., Mork A., Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Research 2008, 1196:41-52.
21. Bergstrom A., Jayatissa M.N., Thykjaer T., Wiborg O. Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study. Journal of Molecular Neuroscience 2007, 33:201-215.
22. Bertrand D. The possible contribution of neuronal nicotinic acetylcholine receptors in depression. Dialogues in Clinical Neuroscience 2005, 7:207-216.
23. Bertrand E., Smadja C., Mauborgne A., Roques B.P., Dauge V. Social interaction increases the extracellular levels of [Met]enkephalin in the nucleus accumbens of control but not of chronic mild stressed rats. Neuroscience 1997, 80:17-20.
24. Bessa J.M., Ferreira D., Melo I., Marques F., Cerqueira J.J., Palha J.A., Almeida O.F., Sousa N. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Molecular Psychiatry 2009, 14:764-773. p. 739.
25. Bhagwagar Z., Hinz R., Taylor M., Fancy S., Cowen P., Grasby P. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. The American Journal of Psychiatry 2006, 163:1580-1587.
26. Bhutani M.K., Bishnoi M., Kulkarni S.K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacology, Biochemistry, and Behavior 2009, 92:39-43.
27. Biegon A., Israeli M. Regionally selective increases in beta-adrenergic receptor density in the brains of suicide victims. Brain Research 1988, 442:199-203.
28. Boldrini M., Underwood M.D., Hen R., Rosoklija G.B., Dwork A.J., John Mann J., Arango V. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009, 34:2376-2389.
29. Bondi C.O., Jett J.D., Morilak D.A. Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex. Progress in Neuro-psychopharmacology & Biological Psychiatry 2010, 34:913-923.
30. Bortolato M., Mangieri R.A., Fu J., Kim J.H., Arguello O., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biological Psychiatry 2007, 62:1103-1110.
31. Bowers G., Cullinan W.E., Herman J.P. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. The Journal of Neuroscience 1998, 18:5938-5947.
32. Cahir M. British association for psychopharmacology summer meeting: 23-26 July 2006, Oxford, United Kingdom. Expert Opinion on Pharmacotherapy 2006, 7:2007-2010.
33. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. The American Journal of Psychiatry 2004, 161:598-607.
34. Cannon D.M., Klaver J.M., Peck S.A., Rallis-Voak D., Erickson K., Drevets W.C. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology 2009, 34:1277-1287.
35. Castren E., Rantamaki T. Neurotrophins in depression and antidepressant effects. Novartis Foundation Symposium 2008, 289:43-52. discussion 53-9, 87-93.
36. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. The Journal of Neuroscience 1986, 6:2908-2914.
37. Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology 1990, 102:544-548.
38. Chen Q.G., Zeng Y.S., Qu Z.Q., Tang J.Y., Qin Y.J., Chung P., Wong R., Hagg U. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2009, 16:830-838.
39. Chen Y., Wang H.D., Xia X., Kung H.F., Pan Y., Kong L.D. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2007, 14:523-529.
40. Choi D.C., Evanson N.K., Furay A.R., Ulrich-Lai Y.M., Ostrander M.M., Herman J.P. The anteroventral bed nucleus of the stria terminalis differentially regulates hypothalamic-pituitary-adrenocortical axis responses to acute and chronic stress. Endocrinology 2008, 149:818-826.
41. Choi D.C., Furay A.R., Evanson N.K., Ulrich-Lai Y.M., Nguyen M.M., Ostrander M.M., Herman J.P. The role of the posterior medial bed nucleus of the stria terminalis in modulating hypothalamic-pituitary-adrenocortical axis responsiveness to acute and chronic stress. Psychoneuroendocrinology 2008, 33:659-669.
42. Cowburn R.F., Marcusson J.O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Research 1994, 633:297-304.
43. Cuadra G., Zurita A., Gioino G., Molina V. Influence of different antidepressant drugs on the effect of chronic variable stress on restraint-induced dopamine release in frontal cortex. Neuropsychopharmacology 2001, 25:384-394.
44. Cullinan W.E., Wolfe T.J. Chronic stress regulates levels of mRNA transcripts encoding beta subunits of the GABA(A) receptor in the rat stress axis. Brain Research 2000, 887:118-124.
45. Cunningham J.I., Raudensky J., Tonkiss J., Yamamoto B.K. MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behavioral Neuroscience 2009, 123:1076-1084.
46. Dalla C., Antoniou K., Kokras N., Drossopoulou G., Papathanasiou G., Bekris S., Daskas S., Papadopoulou-Daifoti Z. Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiology & Behavior 2008, 93:595-605.
47. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., Papadopoulou-Daifoti Z. Chronic mild stress impact: are females more vulnerable?. Neuroscience 2005, 135:703-714.
48. Dang H., Chen Y., Liu X., Wang Q., Wang L., Jia W., Wang Y. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:1417-1424.
49. Dang H., Sun L., Liu X., Peng B., Wang Q., Jia W., Chen Y., Pan A., Xiao P. Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress. Experimental Biology and Medicine (Maywood, N.J.) 2009, 234:785-793.
50. Das A., Rai D., Dikshit M., Palit G., Nath C. Nature of stress: differential effects on brain acetylcholinesterase activity and memory in rats. Life Science 2005, 77:2299-2311.
51. De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Research 1990, 525:71-77.
52. De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Lower cortical beta-adrenoceptor binding sites in post-mortem samples from depressed suicide victims. British Journal of Pharmacology 1989, 98(Suppl.):818P.
53. Devine D.P., Hoversten M.T., Ueda Y., Akil H. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress. Journal of Neuroendocrinology 2003, 15:69-74.
54. Di Chiara G.D., Loddo P., Tanda G. Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biological Psychiatry 1999, 46:1624-1633.
55. Dougherty D.D., Bonab A.A., Ottowitz W.E., Livni E., Alpert N.M., Rauch S.L., Fava M., Fischman A.J. Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks. Depression and Anxiety 2006, 23:175-177.
56. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., Young L.T. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry 1999, 73:1121-1126.
57. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology 2007, 34:865-877.
58. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006, 59:1116-1127.
59. Duncko R., Kiss A., Skultetyova I., Rusnak M., Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 2001, 26:77-89.
60. Dunham J.S., Deakin J.F., Miyajima F., Payton A., Toro C.T. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. Journal of Psychiatric Research 2009, 43:1175-1184.
61. Dwivedi Y., Rizavi H.S., Shukla P.K., Lyons J., Faludi G., Palkovits M., Sarosi A., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biological Psychiatry 2004, 55:234-243.
62. Dwivedi Y., Rao J.S., Rizavi H.S., Kotowski J., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Archives of General Psychiatry 2003, 60:273-282.
63. Dziedzicka-Wasylewska M., Willner P., Papp M. Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behavioural Pharmacology 1997, 8:607-618.
64. Dziedzicka-Wasylewska M., Papp M. Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous Met-enkephalin in the rat dopaminergic mesolimbic system. Polish Journal of Pharmacology 1996, 48:53-56.
65. Elizalde N., Pastor P.M., Garcia-Garcia A.L., Serres F., Venzala E., Huarte J., Ramirez M.J., Del Rio J., Sharp T., Tordera R.M. Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. Journal of Neurochemistry 2010, 114:1302-1314.
66. Elizalde N., Garcia-Garcia A.L., Totterdell S., Gendive N., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacology 2010, 201:393-406.
67. Escriba P.V., Ozaita A., Garcia-Sevilla J.A. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 2004, 29:1512-1521.
68. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nature Reviews. Neuroscience 2009, 10:446-457.
69. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. The Journal of Neuroscience 1996, 16:274-282.
70. Fortunato J.J., Reus G.Z., Kirsch T.R., Stringari R.B., Fries G.R., Kapczinski F., Hallak J.E., Zuardi A.W., Crippa J.A., Quevedo J. Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Research Bulletin 2010, 81:491-496.
71. Froger N., Palazzo E., Boni C., Hanoun N., Saurini F., Joubert C., Dutriez-Casteloot I., Enache M., Maccari S., Barden N., Cohen-Salmon C., Hamon M., Lanfumey L. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. The Journal of Neuroscience 2004, 24:2787-2796.
72. Garcia L.S., Comim C.M., Valvassori S.S., Reus G.Z., Stertz L., Kapczinski F., Gavioli E.C., Quevedo J. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:450-455.
73. Garcia-Garcia A.L., Elizalde N., Matrov D., Harro J., Wojcik S.M., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biological Psychiatry 2009, 66:275-282.
74. Gersner R., Toth E., Isserles M., Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biological Psychiatry 2010, 67:125-132.
75. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Molecular Psychiatry 2002, 7:254-275.
76. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Molecular Psychiatry 2008, 13:717-728.
77. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behavioural Brain Research 2007, 181:42-51.
78. Gronli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., Ursin R., Portas C.M. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacology, Biochemistry, and Behavior 2006, 85:842-849.
79. Gronli J., Murison R., Bjorvatn B., Sorensen E., Portas C.M., Ursin R. Chronic mild stress affects sucrose intake and sleep in rats. Behavioural Brain Research 2004, 150:139-147.
80. Guo J.Y., Huo H.R., Li L.F., Guo S.Y., Jiang T.L. Sini tang prevents depression-like behavior in rats exposed to chronic unpredictable stress. The American Journal of Chinese Medicine 2009, 37:261-272.
81. Guo Y.J., Zhang Z.J., Wang S.H., Sui Y.X., Sun Y. Notch1 signaling, hippocampal neurogenesis and behavioral responses to chronic unpredicted mild stress in adult ischemic rats. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:688-694.
82. Haddjeri N., Blier P., de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. The Journal of Neuroscience 1998, 18:10150-10156.
83. Haidkind R., Eller M., Harro M., Kask A., Rinken A., Oreland L., Harro J. Effects of partial locus coeruleus denervation and chronic mild stress on behaviour and monoamine neurochemistry in the rat. European Neuropsychopharmacology 2003, 13:19-28.
84. Harro J., Tonissaar M., Eller M., Kask A., Oreland L. Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Research 2001, 899:227-239.
85. Harro J., Haidkind R., Harro M., Modiri A.R., Gillberg P.G., Pahkla R., Matto V., Oreland L. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment. European Neuropsychopharmacology 1999, 10:5-16.
86. Hashimoto K., Sawa A., Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biological Psychiatry 2007, 62:1310-1316.
87. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research. Brain Research Review 2004, 45:104-114.
88. Herman J.P., Renda A., Bodie B. Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons. Biological Psychiatry 2003, 53:166-174.
89. Herman J.P., Larson B.R. Differential regulation of forebrain glutamic acid decarboxylase mRNA expression by aging and stress. Brain Reserach 2001, 912:60-66.
90. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995, 61:180-190.
91. Hill M.N., Gorzalka B.B. Impairments in endocannabinoid signaling and depressive illness. JAMA: the Journal of the American Medical Association 2009, 301:1165-1166.
92. Hill M.N., McEwen B.S. Involvement of the endocannabinoid system in the neurobehavioral effects of stress and glucocorticoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010, 34:791-797.
93. Hill M.N., Hillard C.J., Bambico F.R., Patel S., Gorzalka B.B., Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences 2009, 30:484-493.
94. Hill M.N., Carrier E.J., McLaughlin R.J., Morrish A.C., Meier S.E., Hillard C.J., Gorzalka B.B. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. Journal of Neurochemistry 2008, 106:2322-2336.
95. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
96. Hirvonen J., Karlsson H., Kajander J., Markkula J., Rasi-Hakala H., Nagren K., Salminen J.K., Hietala J. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology 2008, 197:581-590.
97. Holderbach R., Clark K., Moreau J.L., Bischofberger J., Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biological Psychiatry 2006, 62:92-100.
98. Holsboer F., Ising M. Stress hormone regulation: biological role and translation into therapy. Annual Review of Psychology 2010, 61:81-109. pp. C1-C11.
99. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
100. Hrdina P., Faludi G., Li Q., Bendotti C., Tekes K., Sotonyi P., Palkovits M. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Molecular Psychiatry 1998, 3:411-418.
101. Hrdina P.D., Demeter E., Vu T.B., Sotonyi P., Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Research 1993, 614:37-44.
102. Hu Y., Liao H.B., Dai-Hong G., Liu P., Wang Y.Y., Rahman K. Antidepressant-like effects of 3,6'-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats. Neurochemistry International 2010, 56:461-465.
103. Hu Y., Liu P., Guo D.H., Rahman K., Wang D.X., Xie T.T. Antidepressant effects of the extract YZ-50 from Polygala tenuifolia in chronic mild stress treated rats and its possible mechanisms. Pharmaceutical Biology 2010, 48:794-800.
104. Hua Y., Huang X.Y., Zhou L., Zhou Q.G., Hu Y., Luo C.X., Li F., Zhu D.Y. DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis. Psychopharmacology 2008, 200:231-242.
105. Hungund B.L., Vinod K.Y., Kassir S.A., Basavarajappa B.S., Yalamanchili R., Cooper T.B., Mann J.J., Arango V. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Molecular Psychiatry 2004, 9:184-190.
106. Iniguez S.D., Vialou V., Warren B.L., Cao J.L., Alcantara L.F., Davis L.C., Manojlovic Z., Neve R.L., Russo S.J., Han M.H., Nestler E.J., Bolanos-Guzman C.A. Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress. The Journal of Neuroscience 2010, 30:7652-7663.
107. Iredale P.A., Terwilliger R., Widnell K.L., Nestler E.J., Duman R.S. Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells. Molecular Pharmacology 1996, 50:1103-1110.
108. Jang C.G., Kang M., Cho J.H., Lee S.B., Kim H., Park S., Lee J., Park S.K., Hong M., Shin M.K., Shim I.S., Bae H. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom. Archives of Pharmacal Research 2004, 27:1065-1072.
109. Jayatissa M.N., Henningsen K., Nikolajsen G., West M.J., Wiborg O. A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress 2010, 13:95-105.
110. Jayatissa M.N., Henningsen K., West M.J., Wiborg O. Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats. Brain Research 2009, 1290:133-141.
111. Jayatissa M.N., Bisgaard C., Tingstrom A., Papp M., Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006, 31:2395-2404.
112. Johnson B.N., Yamamoto B.K. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. The Journal of Pharmacology and Experimental Therapeutics 2010, 335:180-189.
113. Johnson B.N., Yamamoto B.K. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone. Neuroscience 2009, 159:1233-1243.
114. Kang M., Pyun K.H., Jang C.G., Kim H., Bae H., Shim I. Nelumbinis Semen reverses a decrease in hippocampal 5-HT release induced by chronic mild stress in rats. The Journal of Pharmacy and Pharmacology 2005, 57:651-656.
115. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Research. Molecular Brain Research 2005, 136:29-37.
116. Katz R.J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacology, Biochemistry, and Behavior 1982, 16:965-968.
117. Kendler K.S., Karkowski L.M., Prescott C.A. The assessment of dependence in the study of stressful life events: validation using a twin design. Psychological Medicine 1999, 29:1455-1460.
118. Kessler R.C., Gruber M., Hettema J.M., Hwang I., Sampson N., Yonkers K.A. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychological Medicine 2008, 38:365-374.
119. Kessler R.C. Epidemiology of women and depression. Journal of Affective Disorders 2003, 74:5-13.
120. Kessler R.C. The effects of stressful life events on depression. Annual Review of Psychology 1997, 48:191-214.
121. Kessler R.C., Price R.H., Wortman C.B. Social factors in psychopathology: stress, social support, and coping processes. Annual Review of Psychology 1985, 36:531-572.
122. Kim C.K., Yu W., Edin G., Ellis L., Osborn J.A., Weinberg J. Chronic intermittent stress does not differentially alter brain corticosteroid receptor densities in rats prenatally exposed to ethanol. Psychoneuroendocrinology 1999, 24:585-611.
123. Kim H., Whang W.W., Kim H.T., Pyun K.H., Cho S.Y., Hahm D.H., Lee H.J., Shim I. Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress. Brain Research 2003, 983:201-208.
124. Kim S.J., Park S.H., Choi S.H., Moon B.H., Lee K.J., Kang S.W., Lee M.S., Choi S.H., Chun B.G., Shin K.H. Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. Neuropharmacology 2006, 50:824-833.
125. Klimke A., Larisch R., Janz A., Vosberg H., Muller-Gartner H.W., Gaebel W. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Research 1999, 90:91-101.
126. Kong H., Sha L.L., Fan Y., Xiao M., Ding J.H., Wu J., Hu G. Requirement of AQP4 for antidepressive efficiency of fluoxetine: implication in adult hippocampal neurogenesis. Neuropsychopharmacology 2009, 34:1263-1276.
127. Lagunas N., Calmarza-Font I., Diz-Chaves Y., Garcia-Segura L.M. Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Hormones and Behavior 2010, 58:786-791.
128. Larsen M.H., Mikkelsen J.D., Hay-Schmidt A., Sandi C. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. Journal of Psychiatric Research 2010, 44:808-816.
129. Laugeray A., Launay J.M., Callebert J., Surget A., Belzung C., Barone P.R. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Behavioural Brain Research 2010, 210:84-91.
130. Lee K.J., Kim S.J., Kim S.W., Choi S.H., Shin Y.C., Park S.H., Moon B.H., Cho E., Lee M.S., Choi S.H., Chun B.G., Shin K.H. Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus. Experimental & Molecular Medicine 2006, 38:44-54.
131. Lewitus G.M., Wilf-Yarkoni A., Ziv Y., Shabat-Simon M., Gersner R., Zangen A., Schwartz M. Vaccination as a novel approach for treating depressive behavior. Biological Psychiatry 2009, 65:283-288.
132. Li H., Zhang L., Huang Q. Differential expression of mitogen-activated protein kinase signaling pathway in the hippocampus of rats exposed to chronic unpredictable stress. Behavioural Brain Research 2009, 205:32-37.
133. Li J.M., Kong L.D., Wang Y.M., Cheng C.H., Zhang W.Y., Tan W.Z. Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction. Life Science 2003, 74:55-73.
134. Li S., Wang C., Wang W., Dong H., Hou P., Tang Y. Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior. Life Science 2008, 82:934-942.
135. Li S., Wang C., Wang M., Li W., Matsumoto K., Tang Y. Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Science 2007, 80:1373-1381.
136. Li Y.C., Wang F.M., Pan Y., Qiang L.Q., Cheng G., Zhang W.Y., Kong L.D. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:435-449.
137. Li Y.F., Chen H.X., Liu Y., Zhang Y.Z., Liu Y.Q., Li J. Agmatine increases proliferation of cultured hippocampal progenitor cells and hippocampal neurogenesis in chronically stressed mice. Acta Pharmacologica Sinica 2006, 27:1395-1400.
138. Little K.Y., Clark T.B., Ranc J., Duncan G.E. Beta-adrenergic receptor binding in frontal cortex from suicide victims. Biological Psychiatry 1993, 34:596-605.
139. Liu Q., Li B., Zhu H.Y., Wang Y.Q., Yu J., Wu G.C. Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. European Neuropsychopharmacology 2009, 19:796-805.
140. Liu Q., Yu J., Mao-Ying Q.L., Mi W.L., Li B., Wang Y.Q., Wang J., Wu G.C. Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress. The Pharmacogenomics Journal 2008, 8:375-383.
141. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry 1998, 43:547-573.
142. Lopez-Figueroa A.L., Norton C.S., Lopez-Figueroa M.O., Armellini-Dodel D., Burke S., Akil H., Lopez J.F., Watson S.J. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biological Psychiatry 2004, 55:225-233.
143. Lou J.S., Li C.Y., Yang X.C., Fang J., Yang Y.X., Guo J.Y. Protective effect of gan mai da zao decoction in unpredictable chronic mild stress-induced behavioral and biochemical alterations. Pharmaceutical Biology 2010, 48:1328-1336.
144. Lowther S., Crompton M.R., Katona C.L., Horton R.W. GTP gamma S and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls. Molecular Psychiatry 1996, 1:470-477.
145. Lu X., Sharkey L., Bartfai T. The brain galanin receptors: targets for novel antidepressant drugs. CNS & Neurological Disorders Drug Targets 2007, 6:183-192.
146. Lu X., Barr A.M., Kinney J.W., Sanna P., Conti B., Behrens M.M., Bartfai T. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:874-879.
147. Lucca G., Comim C.M., Valvassori S.S., Pereira J.G., Stertz L., Gavioli E.C., Kapczinski F., Quevedo J. Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels. Current Neurovascular Research 2008, 5:207-213.
148. Luo K.R., Hong C.J., Liou Y.J., Hou S.J., Huang Y.H., Tsai S.J. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Progress in Neuro-psychopharmacology & Biological Psychiatry 2010, 34:1433-1439.
149. Machado-Vieira R., Yuan P., Brutsche N., DiazGranados N., Luckenbaugh D., Manji H.K., Zarate C.A. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. The Journal of Clinical Psychiatry 2009, 70:1662-1666.
150. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:1387-1392.
151. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry 1986, 43:954-959.
152. Mao Q.Q., Huang Z., Zhong X.M., Feng C.R., Pan A.J., Li Z.Y., Ip S.P., Che C.T. Effects of SYJN, a Chinese herbal formula, on chronic unpredictable stress-induced changes in behavior and brain BDNF in rats. Journal of Ethnopharmacology 2010, 128:336-341.
153. Mao Q.Q., Xian Y.F., Ip S.P., Tsai S.H., Che C.T. Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behavioural Brain Research 2010, 210:171-177.
154. Mao Q.Q., Ip S.P., Ko K.M., Tsai S.H., Che C.T. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:1211-1216.
155. Mao Q.Q., Ip S.P., Ko K.M., Tsai S.H., Xian Y.F., Che C.T. Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity. Journal of Ethnopharmacology 2009, 124:316-320.
156. Matthews K., Forbes N., Reid I.C. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiology & Behavior 1995, 57:241-248.
157. McKeith I.G., Marshall E.F., Ferrier I.N., Armstrong M.M., Kennedy W.N., Perry R.H., Perry E.K., Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. Journal of Affective Disorders 1987, 13:67-74.
158. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. The Journal of Neuroscience 2004, 24:1478-1485.
159. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., Young T., Praschak-Rieder N., Wilson A.A., Houle S. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Archives of General Psychiatry 2006, 63:1209-1216.
160. Meyer J.H., McMain S., Kennedy S.H., Korman L., Brown G.M., DaSilva J.N., Wilson A.A., Blak T., Eynan-Harvey R., Goulding V.S., Houle S., Links P. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. The American Journal of Psychiatry 2003, 160:90-99.
161. Michel C., Duclos M., Cabanac M., Richard D. Chronic stress reduces body fat content in both obesity-prone and obesity-resistant strains of mice. Hormones and Behavior 2005, 48:172-179.
162. Mineur Y.S., Belzung C., Crusio W.E. Functional implications of decreases in neurogenesis following chronic mild stress in mice. Neuroscience 2007, 150:251-259.
163. Mineur Y.S., Picciotto M.R. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends in Pharmacological Sciences 2010, 31:580-586.
164. Molina V.A., Volosin M., Cancela L., Keller E., Murua V.S., Basso A.M. Effect of chronic variable stress on monoamine receptors: influence of imipramine administration. Pharmacology, Biochemistry, and Behavior 1990, 35:335-340.
165. Molnar M., Potkin S.G., Bunney W.E., Jones E.G. MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biological Psychiatry 2003, 53:39-47.
166. Montgomery A.J., Stokes P., Kitamura Y., Grasby P.M. Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride. Journal of Affective Disorders 2007, 101:113-122.
167. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry 1988, 45:577-579.
168. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
169. Ni Y.G., Gold S.J., Iredale P.A., Terwilliger R.Z., Duman R.S., Nestler E.J. Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. The Journal of Neuroscience 1999, 19:3674-3680.
170. Nibuya M., Takahashi M., Russell D.S., Duman R.S. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neuroscience Letters 1999, 267:81-84.
171. Nowak B., Zadrozna M., Ossowska G., Sowa-Kucma M., Gruca P., Papp M., Dybala M., Pilc A., Nowak G. Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment. Pharmacological Reports 2010, 62:1204-1210.
172. Nowak G., Ossowska G., Jopek R., Papp M. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression. Polish Journal of Pharmacology 1998, 50:365-369.
173. Oomen C.A., Mayer J.L., de Kloet E.R., Joels M., Lucassen P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. The European Journal of Neuroscience 2007, 26:3395-3401.
174. Oquendo M.A., Russo S.A., Underwood M.D., Kassir S.A., Ellis S.P., Mann J.J., Arango V. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biological Psychiatry 2006, 59:235-243.
175. Ordway G.A., Schenk J., Stockmeier C.A., May W., Klimek V. Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression. Biological Psychiatry 2003, 53:315-323.
176. Ortiz J., Fitzgerald L.W., Lane S., Terwilliger R., Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology 1996, 14:443-452.
177. Ossowska G., Nowak G., Klenk-Majewska B., Danilczuk Z., Zebrowska-Lupina I. Effect of imipramine on brain D-1 and 5-HT-2A receptors in a chronic unpredictable stress model in rats, Pol. Polish Journal of Pharmacology 2002, 54:89-93.
178. Ossowska G., Nowa G., Kata R., Klenk-Majewska B., Danilczuk Z., Zebrowska-Lupina I. Brain monoamine receptors in a chronic unpredictable stress model in rats. Journal of Neural Transmission 2001, 108:311-319.
179. Ostrander M.M., Ulrich-Lai Y.M., Choi D.C., Richtand N.M., Herman J.P. Hypoactivity of the hypothalamo-pituitary-adrenocortical axis during recovery from chronic variable stress. Endocrinology 2006, 147:2008-2017.
180. Palumbo M.L., Fosser N.S., Rios H., Zorrilla Zubilete M.A., Guelman L.R., Cremaschi G.A., Genaro A.M. Loss of hippocampal neuronal nitric oxide synthase contributes to the stress-related deficit in learning and memory. Journal of Neurochemistry 2007, 102:261-274.
181. Pan Y., Wang F.M., Qiang L.Q., Zhang D.M., Kong L.D. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology 2010, 35:272-283.
182. Pan Y., Kong L.D., Li Y.C., Xia X., Kung H.F., Jiang F.X. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacology, Biochemistry, and Behavior 2007, 87:130-140.
183. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Roberts R.C., Conley R.R. Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. The International Journal of Neuropsychopharmacology 2007, 10:621-629.
184. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Mondal A.C., Shukla P.K., Conley R.R. Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology 2005, 30:1548-1556.
185. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Roberts R.C., Conley R.R., Tamminga C. Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. Journal of Psychiatric Research 2003, 37:421-432.
186. Pandey G.N., Dwivedi Y., Pandey S.C., Conley R.R., Roberts R.C., Tamminga C.A. Protein kinase C in the postmortem brain of teenage suicide victims. Neuroscience Letters 1997, 228:111-114.
187. Papp M., Nalepa I., Antkiewicz-Michaluk L., Sanchez C. Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model. Pharmacology, Biochemistry, and Behavior 2002, 72:465-474.
188. Papp M., Moryl E., Willner P. Pharmacological validation of the chronic mild stress model of depression. European Journal of Pharmacology 1996, 296:129-136.
189. Papp M., Klimek V., Willner P. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology 1994, 114:309-314.
190. Papp M., Klimek V., Willner P. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 1994, 115:441-446.
191. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Hormones and Behavior 2003, 43:60-66.
192. Parsey R.V., Oquendo M.A., Zea-Ponce Y., Rodenhiser J., Kegeles L.S., Pratap M., Cooper T.B., Van Heertum R., Mann J.J., Laruelle M. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biological Psychiatry 2001, 50:313-322.
193. Patterson Z.R., Ducharme R., Anisman H., Abizaid A. Altered metabolic and neurochemical responses to chronic unpredictable stressors in ghrelin receptor-deficient mice. The European Journal of Neuroscience 2010, 32:632-639.
194. Prewitt C.M., Herman J.P. Hypothalamo-pituitary-adrenocortical regulation following lesions of the central nucleus of the amygdala. Stress 1997, 1:263-280.
195. Prieto M., Gomez F.M., Giralt M.T. Effects of acute, repeated and chronic variable stress on in vivo tyrosine hydroxylase activity and on alpha(2)-adrenoceptor sensitivity in the rat brain. Stress 2003, 6:281-287.
196. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994, 60:436-444.
197. Rasheed N., Ahmad A., Pandey C.P., Chaturvedi R.K., Lohani M., Palit G. Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochemical Research 2010, 35:22-32.
198. Rasheed N., Tyagi E., Ahmad A., Siripurapu K.B., Lahiri S., Shukla R., Palit G. Involvement of monoamines and proinflammatory cytokines in mediating the anti-stress effects of Panax quinquefolium. Journal of Ethnopharmacology 2008, 117:257-262.
199. Raudensky J., Yamamoto B.K. Effects of chronic unpredictable stress on monoamine transporter immunoreactivity and methamphetamine-induced dopamine release in the nucleus accumbens shell. Synapse 2007, 61:353-355.
200. Raudensky J., Yamamoto B.K. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Research 2007, 1135:129-135.
201. Reiach J.S., Li P.P., Warsh J.J., Kish S.J., Young L.T. Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. Journal of Affective Disorders 1999, 56:141-151.
202. Reich C.G., Taylor M.E., McCarthy M.M. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behavioural Brain Research 2009, 203:264-269.
203. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., Lesch K.P. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Molecular Psychiatry 2006, 11:514-522.
204. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety 2000, 12(Suppl. 1):2-19.
205. Reus V.I., Wolkowitz O.M. Antiglucocorticoid drugs in the treatment of depression. Expert Opinion on Investigational Drugs 2001, 10:1789-1796.
206. Rosa-Neto P., Diksic M., Okazawa H., Leyton M., Ghadirian N., Mzengeza S., Nakai A., Debonnel G., Blier P., Benkelfat C. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Archives of General Psychiatry 2004, 61:556-563.
207. Roy M., David N., Cueva M., Giorgetti M. A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biological Psychiatry 2007, 61:174-180.
208. Sandi C., Cordero M.I., Ugolini A., Varea E., Caberlotto L., Large C.H. Chronic stress-induced alterations in amygdala responsiveness and behavior - modulation by trait anxiety and corticotropin-releasing factor systems. The European Journal of Neuroscience 2008, 28:1836-1848.
209. Sergeyev V., Fetissov S., Mathe A.A., Jimenez P.A., Bartfai T., Mortas P., Gaudet L., Moreau J.L., Hokfelt T. Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology 2005, 178:115-124.
210. Sheikh N., Ahmad A., Siripurapu K.B., Kuchibhotla V.K., Singh S., Palit G. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. Journal of Ethnopharmacology 2007, 111:671-676.
211. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. The American Journal of Psychiatry 2003, 160:1516-1518.
212. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. The Journal of Neuroscience 1999, 19:5034-5043.
213. Sheline Y.I. Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity?. Molecular Psychiatry 1996, 1:298-299.
214. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158:1406-1415.
215. Shi C.G., Wang L.M., Wu Y., Wang P., Gan Z.J., Lin K., Jiang L.X., Xu Z.Q., Fan M. Intranasal administration of nerve growth factor produces antidepressant-like effects in animals. Neurochemical Research 2010, 35:1302-1314.
216. Silva R., Mesquita A.R., Bessa J., Sousa J.C., Sotiropoulos I., Leao P., Almeida O.F., Sousa N. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 2008, 152:656-669.
217. Skolnick P., Popik P., Trullas R. Glutamate-based antidepressants: 20 years on. Trends in Pharmacological Sciences 2009, 30:563-569.
218. Song L., Che W., Min-Wei W., Murakami Y., Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacology, Biochemistry, and Behavior 2006, 83:186-193.
219. Sousa N., Almeida O.F., Holsboer F., Paula-Barbosa M.M., Madeira M.D. Maintenance of hippocampal cell numbers in young and aged rats submitted to chronic unpredictable stress. Comparison with the effects of corticosterone treatment. Stress 1998, 2:237-249.
220. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., Moreau J. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. European Journal of Pharmacology 2000, 401:39-46.
221. Sudom K., Turrin N.P., Hayley S., Anisman H. Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice. Neuroimmunomodulation 2004, 11:341-350.
222. Tannenbaum B., Anisman H. Impact of chronic intermittent challenges in stressor-susceptible and resilient strains of mice. Biological Psychiatry 2003, 53:292-303.
223. Tannenbaum B., Tannenbaum G.S., Sudom K., Anisman H. Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Research 2002, 953:82-92.
224. Tata D.A., Yamamoto B.K. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum. Synapse 2008, 62:325-336.
225. Toth E., Gersner R., Wilf-Yarkoni A., Raizel H., Dar D.E., Richter-Levin G., Levit O., Zangen A. Age-dependent effects of chronic stress on brain plasticity and depressive behavior. Journal of Neurochemistry 2008, 107:522-532.
226. Turecki G., Briere R., Dewar K., Antonetti T., Lesage A.D., Seguin M., Chawky N., Vanier C., Alda M., Joober R., Benkelfat C., Rouleau G.A. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. The American Journal of Psychiatry 1999, 156:1456-1458.
227. Valdizan E.M., Gutierrez O., Pazos A. Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to beta-adrenergic stimulation. Biological Psychiatry 2003, 54:1457-1464.
228. van Riel E., Meijer O.C., Steenbergen P.J., Joels M. Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons. Neuroscience 2003, 120:649-658.
229. Vancassel S., Leman S., Hanonick L., Denis S., Roger J., Nollet M., Bodard S., Kousignian I., Belzung C., Chalon S. N-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. Journal of Lipid Research 2008, 49:340-348.
230. Verkuyl J.M., Hemby S.E., Joels M. Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. The European Journal of Neuroscience 2004, 20:1665-1673.
231. Vitale G., Ruggieri V., Filaferro M., Frigeri C., Alboni S., Tascedda F., Brunello N., Guerrini R., Cifani C., Massi M. Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology 2009, 207:173-189.
232. Wang S.H., Zhang Z.J., Guo Y.J., Teng G.J., Chen B.A. Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression. Psychiatry Research 2009, 170:245-251.
233. Wang S.H., Zhang Z.J., Guo Y.J., Teng G.J., Chen B.A. Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress. Behavioural Brain Research 2008, 189:9-16.
234. Wang S.S., Yan X.B., Hofman M.A., Swaab D.F., Zhou J.N. Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress. Neuroscience Bulletin 2010, 26:297-303.
235. Wang W., Sun D., Pan B., Roberts C.J., Sun X., Hillard C.J., Liu Q.S. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010, 35:2249-2261.
236. Webster M.J., Knable M.B., O'Grady J., Orthmann J., Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 2002, 7:985-994. p. 924.
237. Wieronska J.M., Branski P., Szewczyk B., Palucha A., Papp M., Gruca P., Moryl E., Pilc A. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression. Polish Journal of Pharmacology 2001, 53:659-662.
238. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
239. Willner P., Moreau J.L., Nielsen C.K., Papp M., Sluzewska A. Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiology & Behavior 1996, 60:129-134.
240. Willner P. Animal models of depression: validity and applications. Advances in Biochemical Psychopharmacology 1995, 49:19-41.
241. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
242. Wong M.L., Kling M.A., Munson P.J., Listwak S., Licinio J., Prolo P., Karp B., McCutcheon I.E., Geracioti T.D., DeBellis M.D., Rice K.C., Goldstein D.S., Veldhuis J.D., Chrousos G.P., Oldfield E.H., McCann S.M., Gold P.W. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:325-330.
243. Wu H.H., Wang S. Strain differences in the chronic mild stress animal model of depression. Behavioural Brain Research 2010, 213:94-102.
244. Xing G.Q., Russell S., Webster M.J., Post R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. The International Journal of Neuropsychopharmacology 2004, 7:143-153.
245. Xu Q., Yi L.T., Pan Y., Wang X., Li Y.C., Li J.M., Wang C.P., Kong L.D. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Progress in Neuro-psychopharmacology & Biological Psychiatry 2008, 32:715-725.
246. Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., Ogle W.O. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research 2007, 1162:9-18.
247. Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., Li X. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Research 2006, 1122:56-64.
248. Yalcin I., Coubard S., Bodard S., Chalon S., Belzung C. Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice. Psychopharmacology 2008, 200:497-507.
249. Yang L.M., Hu B., Xia Y.H., Zhang B.L., Zhao H. Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus. Behavioural Brain Research 2008, 188:84-90.
250. Yates M., Leake A., Candy J.M., Fairbairn A.F., McKeith I.G., Ferrier I.N. 5HT2 receptor changes in major depression. Biological Psychiatry 1990, 27:489-496.
251. Yau J.L., Noble J., Seckl J.R. Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neuroscience Letters 2001, 309:141-144.
252. Yi L.T., Li J.M., Li Y.C., Pan Y., Xu Q., Kong L.D. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Science 2008, 82:741-751.
253. Yin Y.Y., Ming L., Zheng L.F., Kan H.W., Li C.R., Li W.P. Bioactive compounds from Paecilomyces tenuipes regulating the function of the hypothalamo-hypophyseal system axis in chronic unpredictable stress rats. Chinese Medical Journal 2007, 120:1088-1092.
254. Zhang W., Li J., Zhu J., Shi Z., Wang Y., Kong L. Chinese medicine Banxia-houpu decoction regulates c-fos expression in the brain regions in chronic mild stress model in rats. Phytotherapy Research: PTR 2004, 18:200-203.
255. Zhang X., Dong Y.L., Yang N., Liu Y.Y., Gao R.F., Zuo P.P. Effects of ning shen ling granule and dehydroepiandrosterone on cognitive function in mice undergoing chronic mild stress. Chinese Journal of Integrative Medicine 2007, 13:46-49.
256. Zhang Y., Gu F., Chen J., Dong W. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Research 2010, 1366:141-148.
257. Zheng H., Liu Y., Li W., Yang B., Chen D., Wang X., Jiang Z., Wang H., Wang Z., Cornelisson G., Halberg F. Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behavioural Brain Research 2006, 168:47-55.
258. Zhou Q.G., Hu Y., Hua Y., Hu M., Luo C.X., Han X., Zhu X.J., Wang B., Xu J.S., Zhu D.Y. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. Journal of Neurochemistry 2007, 103:1843-1854.
259. Ziegler D.R., Cullinan W.E., Herman J.P. Organization and regulation of paraventricular nucleus glutamate signaling systems: N-methyl-D-aspartate receptors. The Journal of Comparative Neurology 2005, 484:43-56.
260. Ziegler D.R., Cass W.A., Herman J.P. Excitatory influence of the locus coeruleus in hypothalamic-pituitary-adrenocortical axis responses to stress. Journal of Neuroendocrinology 1999, 11:361-369.